H Jacqmin-Gadda
Overview
Explore the profile of H Jacqmin-Gadda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dartigues J, Grasset L, Helmer C, Feart C, Letenneur L, Jacqmin-Gadda H, et al.
J Prev Alzheimers Dis
. 2017 Dec;
4(1):16-20.
PMID: 29188855
Objectives: To study the benefit of Ginkgo Biloba Extract (GBe) consumption on the long term risk of dementia and death in elderly people. Design: The Paquid study is a population-based...
2.
Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly T, Touchon J, Dubois B, et al.
J Neurol Neurosurg Psychiatry
. 2013 Jul;
85(4):363-70.
PMID: 23840054
Objective: To investigate the sensitivity of a large set of neuropsychological tests to detect cognitive changes due to prodromal Alzheimer's disease(AD); to compare their metrological properties in order to select...
3.
Delva F, Pimouguet C, Helmer C, Peres K, Brechat B, Le Goff M, et al.
Neuroepidemiology
. 2013 Apr;
41(1):20-8.
PMID: 23548733
Background/aims: This study was designed to develop a practical risk score for predicting 5-year survival after the diagnosis of dementia. Methods: Using the Paquid Study (prospective, population-based, long-term cohort study),...
4.
Dantan E, Joly P, Dartigues J, Jacqmin-Gadda H
Biostatistics
. 2011 Mar;
12(4):723-36.
PMID: 21415017
In many chronic diseases, the patient's health status is followed up by quantitative markers. The evolution is often characterized by a 2-phase degradation process, that is, a normal phase followed...
5.
Thiebaut R, Jacqmin-Gadda H, Walker S, Sabin C, Prins M, Del Amo J, et al.
HIV Med
. 2005 Nov;
7(1):1-9.
PMID: 16313286
Objective: To study the determinants of immunological and virological response to highly active antiretroviral therapy (HAART) in naïve patients, adjusting for time since HIV-1 seroconversion. Design: Data from HIV-cohort studies...
6.
Jacqmin-Gadda H, Thiebaut R, Dartigues J
Rev Epidemiol Sante Publique
. 2005 Mar;
52(6):502-10.
PMID: 15741913
Background: In epidemiology, we are often interested in the association between the evolution of a quantitative variable and the onset of an event. The aim of this paper is to...
7.
Hashemi R, Jacqmin-Gadda H, Commenges D
Lifetime Data Anal
. 2004 Mar;
9(4):331-43.
PMID: 15000408
The paper formulates joint modeling of a counting process and a sequence of longitudinal measurements, governed by a common latent stochastic process. The latent process is modeled as a function...
8.
Jacqmin-Gadda H, Thiebaut R, Chene G, Commenges D
Biostatistics
. 2003 Aug;
1(4):355-68.
PMID: 12933561
The classical model for the analysis of progression of markers in HIV-infected patients is the mixed effects linear model. However, longitudinal studies of viral load are complicated by left censoring...
9.
Winnock M, Letenneur L, Jacqmin-Gadda H, Dallongeville J, Amouyel P, Dartigues J
J Neurol Neurosurg Psychiatry
. 2002 May;
72(6):794-7.
PMID: 12023428
Background: The apolipoprotein E (apoE) epsilon4 allele has been shown to be a risk factor for dementia, but it is not clear to what extent apoE affects overall cognitive function...
10.
Journot V, Chene G, Joly P, Saves M, Jacqmin-Gadda H, Molina J, et al.
Control Clin Trials
. 2001 Dec;
22(6):639-58.
PMID: 11738121
In Human Immunodeficiency Virus infection, several statistical methods are available to analyze viral load (HIV-1 RNA) used as a surrogate outcome in trials of antiretroviral treatments. We compared the most...